Skip to main content
eScholarship
Open Access Publications from the University of California

The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis

  • Author(s): Onizawa, M
  • Oshima, S
  • Schulze-Topphoff, U
  • Oses-Prieto, JA
  • Lu, T
  • Tavares, R
  • Prodhomme, T
  • Duong, B
  • Whang, MI
  • Advincula, R
  • Agelidis, A
  • Barrera, J
  • Wu, H
  • Burlingame, A
  • Malynn, BA
  • Zamvil, SS
  • Ma, A
  • et al.

Published Web Location

https://doi.org/10.1038/ni.3172
Abstract

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. A20 is an anti-inflammatory protein linked to multiple human diseases; however, the mechanisms by which A20 prevents inflammatory disease are incompletely defined. We found that A20-deficient T cells and fibroblasts were susceptible to caspase-independent and kinase RIPK3–dependent necroptosis. Global deficiency in RIPK3 significantly restored the survival of A20-deficient mice. A20-deficient cells exhibited exaggerated formation of RIPK1-RIPK3 complexes. RIPK3 underwent physiological ubiquitination at Lys5 (K5), and this ubiquitination event supported the formation of RIPK1-RIPK3 complexes. Both the ubiquitination of RIPK3 and formation of the RIPK1-RIPK3 complex required the catalytic cysteine of A20's deubiquitinating motif. Our studies link A20 and the ubiquitination of RIPK3 to necroptotic cell death and suggest additional mechanisms by which A20 might prevent inflammatory disease.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View